Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Reiteration

Reiteration

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Penny Stocks
  • Price Target
  • Reiteration

Iterum Therapeutics Analyst Remains Bullish Despite Concerns Over FDA Letter

By Nikhil Dayal
Today, 2:54 AM
A lack of clarity and final decision in the U.S. Food and Drug Administration's (FDA) recent letter to Iterum Therapeutics PLC (NASDAQ: ITRM) failed to deter H.C. Wainwright & Co’s bullish sentiment on Iterum stock.

ITRM

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Price Target
  • Reiteration
  • Small Cap

Why A 5-Ship Deal Is Reinforcing This Danaos Analyst’s Bull Case

By Nikhil Dayal
Today, 2:54 AM
A deal involving the acquisition of five ships has furthered a Jefferies analyst's bullish sentiment on Danaos Corp. (NYSE: DAC).

DAC

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • IPOs
  • News
  • Price Target
  • Reiteration

Why The DiDi IPO Is Good News For Uber: BofA

By Shanthi Rexaline
Today, 2:54 AM
Following Chinese ride-hailing giant DiDi Global Inc.'s (NYSE: DIDI) Wall Street debut, an analyst at BofA Securities reiterated a bullish take on U.S.

DASH

Read More
1 minute read
  • Analyst Ratings
  • Media
  • News
  • Reiteration
  • Tech

Craig-Hallum Endorses Magnite’s $31M SpringServe, Reiterates Rating, Price

By Anusuya Lahiri
Today, 2:54 AM
Craig-Hallum analyst Jason Kreyer hailed Magnite Inc’s (NASDAQ:MGNI) acquisition of video ad server SpringServe for $31 million. He…

CMCSA

Read More
3 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • News
  • Price Target
  • Reiteration
  • Tech

Micron Analysts Confident of a Longer Cycle Amid Supply Tightness and Migration to DDR5

By Shanthi Rexaline
Today, 2:54 AM
Micron Technology, Inc. (NASDAQ: MU) reported strong fiscal-year third-quarter results and issued upbeat guidance for the fourth quarter.

AMD

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Price Target
  • Reiteration
  • Tech

Why Microsoft’s AT&T Contract Could Have ‘Measurable Impact’ On Azure Cloud Revenue

By Shanthi Rexaline
Today, 2:54 AM
Although Microsoft Corporation (NASDAQ: MSFT) is playing catch-up with its cloud rival Amazon, Inc.'s (NASDAQ: AMZN) AWS, the software giant is slowly and steadily making strong inroads, according to a Street a

AMZN

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Price Target
  • Reiteration

Why Nvidia Stock Is Trading Higher Today

By Randy Elias
Today, 2:54 AM
NVIDIA Corporation (NASDAQ: NVDA) shares were trading higher Thursday after BMO Capital maintained an Outperform rating on the stock and raised its price target from $750 to a new Street high of $1,000.

NVDA

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Media
  • Price Target
  • Reiteration
  • Trading Ideas

Should You Buy Fox Stock Now? Analyst Shares 5 Reasons Why

By Wayne Duggan
Today, 2:54 AM
Fox Corp (NASDAQ: FOX) has significantly lagged the S&P 500 in the past three months, but one analyst has listed at least five reasons why investors should be buying the dip in Fox.

DIS

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Price Target
  • Reiteration

Why This Tesla Stock Analyst Lowered Their Price Target By 10%

By Shanthi Rexaline
Today, 2:54 AM
The consumer appetite to buy a battery electric vehicle is at a new high globally, and Tesla, Inc. (NASDAQ: TSLA) continues to be the undisputed leader — but it is threatened by competition, an analyst at UBS said Tuesday.

BMWYY

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Price Target
  • Reiteration

Intellia Therapeutics Analyst Doubles Price Target: What You Need To Know

By Nikhil Dayal
Today, 2:54 AM
An SVB Leerink genetic medicine analyst is bullish on shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA). Here's why. 

NTLA

Posts navigation

Previous 1 … 267 268 269 … 272 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service